Respiratory syncytial virus (RSV) has been linked to the exacerbation of cardiovascular conditions in patients with pre-existing diagnoses and those without known cardiovascular disease. RSV vaccination is now recommended for all adults ages 75 or older, and individuals ages 50-74 with risk factors. The optimal time for vaccination is before the winter. © 2025 American Heart Association, Inc., 501(c)(3) not-for-profit. All rights reserved. Lifelong Learning is a trademark of the AHA. Unauthorized use prohibited. WF-1047100 9/25 VIDEOS ON DEMAND Understanding RSV in Adults: Burden of Disease & Risk Factors for Severe Illness Experts discuss how to recognize the burden of this disease in adults to better educate patients on the potential benefits of RSV prevention as well as chronic conditions and risk factors associated with increased risk of severe RSV. CE and MOC Credits Available. Strategies to Increase RSV Vaccinations A panel of experts discuss the new RSV vaccination recommendations for adults aged 50 or older, clinical considerations for timing of RSV vaccination and co-administration with other vaccines. CE and MOC Credits Available. This medical education is supported by Pfizer. Explore a variety of accredited educational resources. Education on your time. Start now! RSV in Older Adults and High-Risk Individuals Paid Advertisement
RkJQdWJsaXNoZXIy MjI2NjI=